TEMA ETFs

TEMA ETFs

TEMA ETFs was founded in 2023 by Maurits Pot, drawing on his experience across institutional asset management and equity derivatives structuring at firms including Goldman Sachs and Amundi. The firm positions itself as a thematic active ETF issuer, translating high-conviction secular growth narratives into liquid portfolios that can be traded intraday. Its vehicle architecture is notable: each fund is actively managed and concentrated, typically holding 20-40 names, which breaks from the broad-based, rules-based indexes that dominate thematic ETF shelves. The firm's launch lineup targeted structural supply gaps in healthcare innovation, automation, and energy transition. Its initial funds include the TEMA Oncology ETF, the TEMA American Reshoring ETF, and the TEMA Cardiovascular and Metabolic ETF, with each portfolio assembled through fundamental bottom-up research rather than passive replication. The American Reshoring ETF, for instance, invests in US-based industrials, automation providers, and semiconductor manufacturers that stand to benefit from supply-chain relocation back to North America. TEMA enters a thematic ETF market that swelled past $240 billion in global assets by 2024 (per Morningstar, 2024), but it differentiates by concentrating risk — the opposite of diversification — betting that allocators will pay active fees for genuine stock selection inside a tax-efficient ETF chassis. TEMA functions as a lean investment adviser with a New York base. The firm enters a field shaped by incumbents like ARK Invest, Global X, and Defiance, though TEMA enters after the 2022 thematic drawdown that punished the highest-profile names in the category. The timing suggests a second-act thesis: in 2024, TEMA expanded its suite with the launch of the TEMA AI & Genomics ETF, which targets the convergence of large-scale biological data generation and machine learning interpretation — a niche at the intersection of two research-intensive disciplines. The structural differentiator is TEMA's insistence on an active-share discipline inside an ETF, a format where most thematic peers use passive or factor-based methodologies. By registering as active, TEMA retains the right to override any benchmark when fundamentals shift, sidestepping the forced-buying problem that afflicts index-based thematic funds during momentum-driven rallies. This is paired with an intentionally sparse product shelf rather than a volume-driven launch calendar, making the firm's economics tied to the performance of a small number of concentrated funds rather than scale-gathering across a wide fee-basis.